Literature DB >> 12917273

Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience.

Y J Chou1, Winnie C Yip, Cheng-Hua Lee, Nicole Huang, Ying-Pei Sun, Hong-Jen Chang.   

Abstract

In many Asian countries, physicians both prescribe and dispense drugs. This practice is hypothesized to have caused high drug expenditure and widespread prescription of antibiotics in Asia. Recently, Taiwan implemented the separation policy on an experimental basis. This paper's objective is to empirically evaluate the impact of Taiwan's reform to separate drug prescribing and dispensing on drug expenditure and total health expenditure. The research design consists of a pre/post comparison of the experimental with the control sites (difference-in-difference). Separation policy was implemented in Kaohsung and Taipei in March 1997, and expanded to Chia-yi and Taichung in March 1998. Changes in drug prescription behaviour before and after implementation in these two pairs of experimental cities were compared to Hsin-chu and Tainan (control), where separation policy was not implemented during the study period. To reduce resistance, providers in experimental sites were allowed to hire on-site pharmacists and dispense drugs through them if they chose to do so. Our study sample consists of all outpatient visits to clinics in the study sites between December 1996 and June 1998, with a total of 55.23 million claim records. The drug prescription rate, drug expenditure and total health expenditure per visit were the main outcome measures. We found that the probability of prescription and drug expenditure per visit were, respectively, 17-34% and 12-36% less among visits to clinics without on-site pharmacists, compared with the control sites. However, no difference in total health expenditure was found between these two types of visits. Hence, the separation policy could be effective in reducing drug expenditure and affecting prescription behaviour, but is less certain as a policy for reducing total health expenditure. We also found that the policy has practically no effect on clinics that have on-site pharmacists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917273     DOI: 10.1093/heapol/czg038

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  17 in total

1.  Is there a role for pharmacoeconomics in developing countries?

Authors:  Zaheer-Ud-Din Babar; Shane Scahill
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  There should only be one most responsible provider.

Authors:  Eugene Y H Yeung
Journal:  Can Pharm J (Ott)       Date:  2020-09-25

3.  Antibiotics Dispensing for URTIs by Community Pharmacists (CPs) and General Medical Practitioners in Penang, Malaysia: A Comparative Study using Simulated Patients (SPs).

Authors:  Alamin Hassan M A Alabid; Mohamed Izham Mohamed Ibrahim; Mohamed Azmi Hassali
Journal:  J Clin Diagn Res       Date:  2014-01-12

4.  Appropriateness of ambulatory prescriptions in Taiwan: translating claims data into initiatives.

Authors:  Yunn-Fang Ho; Ling-Ling Hsieh; Wan-Chen Lu; Fu-Chang Hu; Kenneth M Hale; Shu-Jen Lee; Fang-Ju Lin
Journal:  Int J Clin Pharm       Date:  2011-12-03

5.  The healer or the druggist: effects of two health care policies in Taiwan on elderly patients' choice between physician and pharmacist services.

Authors:  Kang-Hung Chang
Journal:  Int J Health Care Finance Econ       Date:  2009-04-09

6.  Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis.

Authors:  John J Kim; Adeline H Tian; Lee Pham; Nardine Nakhla; Sherilyn K D Houle; William W L Wong; Mhd Wasem Alsabbagh
Journal:  Int J Pharm Pract       Date:  2021-05-25

7.  Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.

Authors:  Shiou-Huei Huang; Chien-Ning Hsu; Shu-Hui Yu; Thau-Ming Cham
Journal:  BMC Public Health       Date:  2012-05-31       Impact factor: 3.295

8.  Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers.

Authors:  Fatima Suleman; Espen Movik
Journal:  Cochrane Database Syst Rev       Date:  2019-11-13

9.  The influences of Taiwan's generic grouping price policy on drug prices and expenditures: evidence from analysing the consumption of the three most-used classes of cardiovascular drugs.

Authors:  Chi-Liang Chen; Likwang Chen; Wei-Chih Yang
Journal:  BMC Public Health       Date:  2008-04-12       Impact factor: 3.295

10.  Dosing variability in prescriptions of acetaminophen to children: comparisons between pediatricians, family physicians and otolaryngologists.

Authors:  Yueh-Ching Chou; Shin-Yi Lin; Tzeng-Ji Chen; Shu-Chiung Chiang; Mei-Jy Jeng; Li-Fang Chou
Journal:  BMC Pediatr       Date:  2013-04-24       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.